{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:21:41Z","timestamp":1769973701612,"version":"3.49.0"},"reference-count":28,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1136\/dtb.2019.229180rep","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:20:41Z","timestamp":1585700441000},"page":"93-95","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Republished: Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking lamotrigine"],"prefix":"10.1136","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8302-3037","authenticated-orcid":false,"given":"Catarina","family":"Lameiras","sequence":"first","affiliation":[{"name":"Hospital Professor Doutor Fernando Fonseca EPE, Amadora, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9nia","family":"Ornelas","sequence":"additional","affiliation":[{"name":"Hospital Professor Doutor Fernando Fonseca EPE, Amadora, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mendes Lopes","sequence":"additional","affiliation":[{"name":"Hospital Professor Doutor Fernando Fonseca EPE, Amadora, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do C\u00e9u","family":"D\u00f3ria","sequence":"additional","affiliation":[{"name":"Hospital Professor Doutor Fernando Fonseca EPE, Amadora, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"2025082723213271000_58.6.93.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033"},{"key":"2025082723213271000_58.6.93.2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195901\/02)12:1<164::AID-CNCR2820120122>3.0.CO;2-Y"},{"key":"2025082723213271000_58.6.93.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.01.017"},{"key":"2025082723213271000_58.6.93.4","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18383"},{"key":"2025082723213271000_58.6.93.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05584.x"},{"key":"2025082723213271000_58.6.93.6","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962012000300013"},{"key":"2025082723213271000_58.6.93.7","first-page":"556","article-title":"Clinical features of drug-induced hypersensitivity syndrome in 38 patients","volume":"20","author":"SJ","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2025082723213271000_58.6.93.8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (dress): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025082723213271000_58.6.93.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03637.x"},{"key":"2025082723213271000_58.6.93.10","first-page":"139","article-title":"Drug reaction with eosinophilia and systemic symptoms (dress): incidence, pathogenesis and management","volume":"16","author":"Shiohara","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"2025082723213271000_58.6.93.11","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.198"},{"key":"2025082723213271000_58.6.93.12","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501"},{"key":"2025082723213271000_58.6.93.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.02.1130"},{"key":"2025082723213271000_58.6.93.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2010.03.004"},{"key":"2025082723213271000_58.6.93.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2009.04.007"},{"key":"2025082723213271000_58.6.93.16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jdv.12419","article-title":"Recurrence of drug-induced reactions in dress patients","volume":"29","author":"Picard","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025082723213271000_58.6.93.17","first-page":"321","article-title":"Drug neosensitization during anticonvulsant hypersensitivity syndrome","volume":"16","author":"Gaig","year":"2006","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2025082723213271000_58.6.93.18","doi-asserted-by":"crossref","first-page":"068","DOI":"10.1684\/ejd.2010.0821","article-title":"Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro","volume":"20","author":"Mardivirin","year":"2010","journal-title":"Eur J Dermatology"},{"key":"2025082723213271000_58.6.93.19","first-page":"142","article-title":"Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"2025082723213271000_58.6.93.20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.dsi.2013.09.006","article-title":"Drug reaction with eosinophilia and systemic symptoms: a drug-induced hypersensitivity syndrome with variable clinical features","volume":"31","author":"Chen","year":"2013","journal-title":"Dermatologica Sinica"},{"key":"2025082723213271000_58.6.93.21","unstructured":"FDA Drug Safety Communication . Fda warns of serious immune system reaction with seizure and mental health medicine lamotrigine (Lamictal). Available: www.fda.gov [Accessed 10 Jun 2018]."},{"key":"2025082723213271000_58.6.93.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(96)80038-1"},{"key":"2025082723213271000_58.6.93.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07807.x"},{"key":"2025082723213271000_58.6.93.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07284.x"},{"key":"2025082723213271000_58.6.93.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.032"},{"key":"2025082723213271000_58.6.93.26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2332\/allergolint.10-RAI-0260","article-title":"Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy","volume":"59","author":"Shiohara","year":"2010","journal-title":"Allergology International"},{"key":"2025082723213271000_58.6.93.27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/17425255.2017.1297422","article-title":"Prediction and management of drug reaction with eosinophilia and systemic symptoms (dress)","volume":"13","author":"Shiohara","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2025082723213271000_58.6.93.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2010.04.024"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2019.229180rep","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:21:42Z","timestamp":1756362102000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2019.229180rep"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,5,27]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/dtb.2019.229180rep"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2019.229180rep","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}